Upcoming Events and meetings
SYMPOSIUM: February 8th & 11th. In response to the ongoing COVID-19 situation, we have decided to alter the programme to accommodate a session on COVID-19 in place of the planned therapeutic session. Diagnostic session remains unchanged.
Call for Additional Abstract Submissions
We invite submissions of additional abstracts for the training days. We urge Principal Investigators to encourage their students and post-docs to present posters, as it affords an excellent opportunity for initiating & furthering collaborations, and for your team to discuss their work with others in the field in a friendly and informal environment. There will be prizes for best poster and oral presentation. A completed SUBMISSION FORM should be returned to firstname.lastname@example.org by 5th January 2021 at the latest.
Conference postponed to June 12-17, 2021
The purpose of the 17th Innate Immunity is to bring together scientists from all over the world to discuss their latest findings on the various aspects of Innate Immunity.
The specific topics include: Evolution of the innate immune system, Host-microbe interactions, Interactions with adaptive immunity, Neuroimmunology, Pathophysiology-Inflammation, Structural biology, and Therapeutic applications.
Conference postponed to June 17-22, 2021
This conference aims to bring together academic and industry scientists and clinical development experts who are focused on contemporary and emerging aspects of complement-mediated disease pathogenesis and the development of therapeutics that modulate this system in a beneficial manner. Topics discussed during the conference include: Molecular mechanisms and targets in complement-related diseases; Novel inhibitors & pipeline compounds; Haematological disorders; Organ & cell transplantation, I/R injury and chronic rejection; Kidney diseases; Neurological & ocular diseases; Acute and chronic inflammatory disorders; Infectious diseases & sepsis; Cancer; Informative complement biomarkers in therapeutic development; Novel and unexpected indications
This 3rd conference on Antibodies & Complement will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. Some of the critical topics to be covered include:
- antibody & complement (novel) functions
- human antibody repertoires
- complement structure and subcellular localization
- novel technologies
- complement and antibody therapies
After the success of the two first editions (EMBO workshop June 2018 & May 2019), this third edition of conference on Antibodies & Complement should again be a forum for leaders in the field and new investigators coming from academia, industry and research institutes to discuss where the field is going and what challenges lie ahead.
The Frontiers Meeting 2021 is an International Society of Nephrology (ISN) event hosted by the Mario Negri Institute for Pharmacological Research.
The 2021 Frontiers Meeting will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS) and C3 Glomerulopathies /Membranoproliferative Glomerulonephritis (C3G/MPGN), both very rare and severe diseases. aHUS is an ultra-rare disease with an estimated prevalence of 1/100,000, while primary C3G/MPGN has an estimated prevalence of 16/100,000.